Evidence map›Paper›PMID 38641715›Full record

ArticleActa neuropathologica2024

Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion.

Evan Udine, Mariely DeJesus-Hernandez, Shulan Tian, Sofia Pereira das Neves, Richard Crook, NiCole A Finch, Matthew C Baker, Cyril Pottier, Neill R Graff-Radford, Bradley F Boeve and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Acta neuropathologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 2 countries.

Evan UdineDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Mariely DeJesus-HernandezDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Shulan TianDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, 55905, USA.
Sofia Pereira das NevesDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Richard CrookDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
NiCole A FinchDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Matthew C BakerDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Cyril PottierDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Neill R Graff-RadfordDepartment of Neurology, Mayo Clinic, Jacksonville, FL, 32224, USA.
Bradley F BoeveDepartment of Neurology, Rochester, MN, 55905, USA.
Ronald C PetersenDepartment of Neurology, Rochester, MN, 55905, USA.
David S KnopmanDepartment of Neurology, Rochester, MN, 55905, USA.
Keith A JosephsDepartment of Neurology, Rochester, MN, 55905, USA.
Björn OskarssonDepartment of Neurology, Mayo Clinic, Jacksonville, FL, 32224, USA.
Sandro Da MesquitaDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Leonard PetrucelliDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Tania F GendronDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Rosa RademakersDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.
Marka van BlitterswijkDepartment of Neuroscience, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA. VanBlitterswijk.Marka@mayo.edu.ORCID 0000-0002-3054-7053
Mayo Clinic in Florida · USUniversity of Minnesota Rochester · USJacksonville College · USUniversity of Antwerp · BE

Funding

Project 3: Neuropathology of the multi-proteinopathy of c9FTD/ALS.P01NS084974 · NINDS · MAYO CLINIC JACKSONVILLE · PI PETRUCELLI, LEONARD · 2014 to 2024
$17.6M
Expanding insights into FTD disease mechanismsR35NS097273 · NINDS · MAYO CLINIC JACKSONVILLE · PI PETRUCELLI, LEONARD · 2017 to 2024
$10.6M
Understanding the role of TDP-43 in Alzheimers disease and FTLDR01AG037491 · NIA · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A · 2010 to 2024
$6.5M
Stathmin-2 and TDP-43 neurodegeneration in Alzheimer’s and multi-etiology dementiasRF1NS120992 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Keith A Josephs, Mercedes Prudencio · 2021 to 2026
$4.2M
Frontotemporal dementia and related disorders: transcriptomic profiling, biomarker discovery, and mechanistic insightR01NS121125 · NINDS · MAYO CLINIC JACKSONVILLE · PI GENDRON, TANIA FRANCE, VAN BLITTERSWIJK, MARKA · 2021 to 2025
$3.9M
Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathologyUH3NS103870 · NINDS · MAYO CLINIC JACKSONVILLE · PI RADEMAKERS, ROSA · 2019 to 2021
$3.7M
Genetic Discovery and Pathobiology of Frontotemporal Lobar Degeneration and Related TDP-43 ProteinopathiesR35NS097261 · NINDS · MAYO CLINIC JACKSONVILLE · PI RADEMAKERS, ROSA · 2017 to 2019
$2.9M
C9orf72-mediated features, transcriptomic signatures, and translational studies for frontotemporal dementia and related disordersRF1NS123052 · NINDS · MAYO CLINIC JACKSONVILLE · PI VAN BLITTERSWIJK, MARKA · 2022 to 2022
$2.4M
Role of apoE-mediated meningeal lymphatic remodeling in the pathophysiology of Alzheimer’s diseaseRF1AG080556 · NIA · MAYO CLINIC JACKSONVILLE · PI DA MESQUITA, SANDRO · 2023 to 2023
$2.3M
Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathologyUG3NS103870 · NINDS · MAYO CLINIC JACKSONVILLE · PI RADEMAKERS, ROSA · 2017 to 2018
$1.9M
Stathmin-2 and TDP-43 neurodegeneration in Alzheimer’s and multi-etiology dementiasR01NS120992 · NINDS · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A, PRUDENCIO, MERCEDES · 2024 to 2025
$1.6M
Uncovering RNA signatures of C9ORF72-linked ALS and related disordersR21NS110994 · NINDS · MAYO CLINIC JACKSONVILLE · PI VAN BLITTERSWIJK, MARKA · 2019 to 2019
$430k
NIA NIH HHS R01 AG037491NIA NIH HHS RF1 AG080556NINDS NIH HHS P01 NS084974NINDS NIH HHS R01 NS120992NINDS NIH HHS R01 NS121125NINDS NIH HHS R21 NS110994NINDS NIH HHS R35 NS097261NINDS NIH HHS R35 NS097273NINDS NIH HHS RF1 NS120992NINDS NIH HHS RF1 NS123052NINDS NIH HHS UG3 NS103870NINDS NIH HHS UH3 NS103870
6 · The paper itself

Abstract

The most prominent genetic cause of both amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) is a repeat expansion in the gene C9orf72. Importantly, the transcriptomic consequences of the C9orf72 repeat expansion remain largely unclear. Here, we used short-read RNA sequencing (RNAseq) to profile the cerebellar transcriptome, detecting alterations in patients with a C9orf72 repeat expansion. We focused on the cerebellum, since key C9orf72-related pathologies are abundant in this neuroanatomical region, yet TDP-43 pathology and neuronal loss are minimal. Consistent with previous work, we showed a reduction in the expression of the C9orf72 gene and an elevation in homeobox genes, when comparing patients with the expansion to both patients without the C9orf72 repeat expansion and control subjects. Interestingly, we identified more than 1000 alternative splicing events, including 4 in genes previously associated with ALS and/or FTLD. We also found an increase of cryptic splicing in C9orf72 patients compared to patients without the expansion and controls. Furthermore, we demonstrated that the expression level of select RNA-binding proteins is associated with cryptic splice junction inclusion. Overall, this study explores the presence of widespread transcriptomic changes in the cerebellum, a region not confounded by severe neurodegeneration, in post-mortem tissue from C9orf72 patients.

Indexed as

Amyotrophic Lateral SclerosisC9orf72 ProteinCerebellumFrontotemporal Lobar DegenerationDNA Repeat ExpansionGene Expression ProfilingHumansTranscriptomeC9orf72 ProteinC9orf72 protein, humanAmyotrophic lateral sclerosisC9orf72Cryptic exonsFrontotemporal lobar degenerationTranscriptomics

Identifiers

PMID38641715
PMCPMC11031479
OpenAlexW4394947223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.